Jan 13, 2020 / 07:30PM GMT
Tejas Rajeev Savant - JP Morgan Chase & Co, Research Division - Analyst
Good morning, everyone. My name is Tejas Savant, and I work on the Life Sciences team at JPMorgan. It's my pleasure this morning to introduce Helmy Eltoukhy, CEO and Founder of Guardant Health. At the end of Helmy's presentation, there will be a breakout with management in the Olympic Room.
And with that, I'd like to hand it over to Helmy.
Helmy Eltoukhy - Guardant Health, Inc. - Co-Founder, CEO & Director
Thank you, Tejas. It's always exciting to be here, and thank you for the invitation this week. Please note our forward-looking statement.
When we started Guardant several years ago, we were frustrated by the slow rate of progress in health care, and more specifically, oncology. We believe that this fundamentally came down to a lack of data, data that was largely locked away inside tumor tissue, serving as a bottleneck to our collective understanding of how tumors grow, evolve and change over time, and especially in response to applied interventions. We believe
Guardant Health Inc at JPMorgan Healthcare Conference Transcript
Jan 14, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers